BioCryst Pharmaceutical Inc. (BCRX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4505 EMPEROR BOULEVARD DURHAM, NC 27703

BioCryst Pharmaceutical Inc. operates as a biopharmaceutical company which uses structure-based drug design to discover and design novel, small-molecule pharmaceutical products for the treatment of cancer, cardiovascular and autoimmune diseases and viral infections.

Data as of 2020-05-30
Market Cap693.368 Million Shares Outstanding154.357 Million Avg 30-day Volume13.923 Million
P/E Ratio Dividend Yield EPS-0.9
Price/Sales14.524 Price cash flow ratio Price free cash flow ratio-8.0
Book Value0.02 Price to Tangible Book190.2 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.229553
BETA2.7728 52-week High/Low6.2862 / 1.38 Stddev0.246992
View SEC Filings from BCRX instead.

View recent insider trading info

Funds Holding BCRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUTSON NANCY J

  • Director
0 2020-06-03 6

INGRAM ROBERT ALEXANDER

  • Director
65,087 2020-06-01 6

HEGGIE THERESA

  • Director
11,204 2020-06-01 6

ASELAGE STEVE

  • Director
26,204 2020-06-01 6

COHEN FRED E

  • Director
0 2020-05-18 0

JENSEN PEDER

  • Director
0 2020-05-14 0

STONEHOUSE JON P PRESIDENT & CEO

  • Officer
  • Director
0 2020-05-13 5

ABERCROMBIE GEORGE B

  • Director
0 2020-05-12 1

LEE KENNETH B JR

  • Director
0 2020-05-12 2

THACKRAY HELEN M.

  • Director
0 2020-05-12 3

LEVIN ALAN G

  • Director
0 2020-05-12 3

DOYLE ANTHONY CHIEF FINANCIAL OFFICER

  • Officer
0 2020-04-30 2

PATEL SANJ K CHAIRMAN & CEO

  • Officer
  • Director
0 2020-03-13 0

ERCK STANLEY C PRESIDENT AND CEO

  • Officer
  • Director
20,494 2020-03-08 0

STAAB THOMAS R II SENIOR VICE PRESIDENT AND CFO

  • Officer
0 2020-02-21 4

BABU YARLAGADDA S SENIOR VP - DRUG DISCOVERY

  • Officer
0 2020-02-21 4

SHERIDAN WILLIAM P SENIOR VP - CMO

  • Officer
0 2020-02-21 3

BARNES ALANE P SENIOR VP, CHIEF LEGAL OFFICER

  • Officer
0 2020-02-21 4

JONES MICHAEL L EXEC. DIRECTOR, FINANCE - PAO

  • Officer
0 2020-02-21 3

HIGGINS JOHN L CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
205,173 2020-02-13 0

GAYER CHARLES K VICE PRESIDENT AND CCO

  • Officer
127,315 2020-01-15 1

SNIECINSKI MEGAN CHIEF BUSINESS OFFICER

  • Officer
0 2019-12-17 5

SEIDENBERG BETH C

  • Director
17,698,819 2019-10-29 0

STEER RANDOLPH C

  • Director
4,721 2019-10-24 0

BAKER BROS. ADVISORS LP

BAKER BROS. INVESTMENTS II, L.P.

BAKER BROS. INVESTMENTS, L.P.

BAKER/TISCH INVESTMENTS, LP

14159, L.P.

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
9,471,630 2019-08-29 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
4,685,574 2019-07-01 0

POWELL LYNNE SENIOR VP - CCO

  • Officer
0 2019-01-25 0

LOWREY ROBERT S CFO, TREASURER, SECRETARY

  • Officer
1,000,000 2018-08-01 0

BIGGAR STEPHEN R

  • Director
0 2018-05-23 0

GRANT STUART EVP AND CFO

  • Officer
No longer subject to file 2017-08-29 0

SANDERS CHARLES A

  • Director
12,971 2016-02-29 0

HOROVITZ ZOLA P

  • Director
250,666 2015-12-08 0

BAKER BROS. ADVISORS (GP) LLC

  • Director
  • 10% Owner
0 2013-07-01 0

BAKER BROS ADVISORS LLC

  • 10% Owner
0 2012-04-12 0

MCCULLOUGH DAVID VP

  • Officer
24,124 2012-03-15 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
2,328,863 2012-03-12 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
57,704 2012-03-12 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
232,011 2012-03-12 0

BAKER BROS. CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
0 2012-01-27 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
450,461 2011-12-30 0

FEATHERINGILL WILLIAM W

  • Director
  • 10% Owner
0 2010-05-13 0

MILLS MIKE PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2010-03-12 0

DARWIN MICHAEL A PRINCIPAL ACCOUNTING OFFICER

  • Officer
3,048 2008-07-31 0

BENNETT J CLAUDE CHIEF OPERATING OFFICER

  • Officer
  • Director
0 2008-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ASELAGE STEVE - Director

2020-06-01 A 1,112 $4.50 a 26,204 26,204.00 direct

INGRAM ROBERT ALEXANDER - Director

2020-06-01 A 4,171 $4.50 a 65,087 65,087.00 direct

HUTSON NANCY J - Director

2020-06-01 A 2,224 $4.50 a 62,111 62,111.00 direct

HEGGIE THERESA - Director

2020-06-01 A 1,112 $4.50 a 11,204 11,204.00 direct

STONEHOUSE JON P - Director - Officer PRESIDENT & CEO

2020-05-13 A 157,250 a 157,250 0.00 direct

THACKRAY HELEN M. - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

LEE KENNETH B JR - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

HUTSON NANCY J - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

ABERCROMBIE GEORGE B - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

LEVIN ALAN G - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

ASELAGE STEVE - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

INGRAM ROBERT ALEXANDER - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

HEGGIE THERESA - Director

2020-05-12 A 40,000 a 40,000 0.00 direct

DOYLE ANTHONY - Officer CHIEF FINANCIAL OFFICER

2020-04-30 A 600,000 a 600,000 0.00 direct

Elevate your investments